Advanced Pharma CR | Miami, FL

Research site

(Unclaimed)

Location

2950 NW 83rd St, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

INCB050465

S-217622

Ruxolitinib

Bococizumab

ASP0367

Filgotinib

Pregabalin

Dapagliflozin

ION224

Brazikumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 81 total trials

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

This clinical trial is a Phase 2/3 study that will evaluate the efficacy and safety of etavopivat and test how well etavopivat works compared to plac...

Active, not recruiting

Sickle Cell Disease

Drug: Placebo Tablets

Drug: Etavopivat Tablets High dose

A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)

The goal of the study is to learn what happens to different forms of sotatercept medications in a healthy person's body over time. Researchers want t...

Active, not recruiting

Healthy

Biological: Sotatercept

Biological: Sotatercept Autoinjector

A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

The purpose of this study is to assess the effect of severe renal impairment (RI) and end-stage renal disease (ESRD) with intermittent hemodialysis (...

Enrolling

Renal Impairment

Healthy Volunteers

Drug: BMS-986278

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) (U-ACHIEVE)

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting

Ulcerative Colitis (UC)

Drug: Placebo

Drug: Upadacitinib (ABT-494)

An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

This a phase 1, open label, single dose, parallel cohort study to determine the pharmacokinetics (PK) of study drug (ESK-001) in healthy volunteer pa...

Enrolling

Renal Impairment

Drug: ESK-001

Locations recently updated

Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happe...

Enrolling

Diabetes Mellitus, Type 2

Drug: MK-2828

Drug: Placebo

SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of KSHN001126 in Healthy Post-Menopausal Females

This is an Open-label, Sequential dosing, Single Ascending Dose (SAD) Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile o...

Not yet enrolling

Healthy Postmenopausal Women

Drug: KSHN001126 150mg

Drug: KSHN001126 600mg

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE)

This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the effi...

Active, not recruiting

Cirrhosis

Prevention of Esophageal Varices

Drug: belapectin

Drug: Placebo